TipRanks
Advertisement
Advertisement

CH:SDZ Stock Latest News

Sandoz price target raised to CHF 60 from CHF 55 at Morgan Stanley
The FlySandoz price target raised to CHF 60 from CHF 55 at Morgan Stanley
4d ago
Sandoz boosts European biosimilar capacity with new Slovenian plant
PremiumCompany Announcements
Sandoz boosts European biosimilar capacity with new Slovenian plant
12d ago
mAbxience, Sandoz sign collaboration agreement for biosimilar access
PremiumThe Fly
mAbxience, Sandoz sign collaboration agreement for biosimilar access
22d ago
Sandoz joins mAbxience to develop emicizumab biosimilar and expand haemophilia pipeline
PremiumCompany Announcements
Sandoz joins mAbxience to develop emicizumab biosimilar and expand haemophilia pipeline
23d ago
Sandoz Wins Canadian Approval for Generic Semaglutide, Targeting Growing GLP-1 Market
PremiumCompany Announcements
Sandoz Wins Canadian Approval for Generic Semaglutide, Targeting Growing GLP-1 Market
23d ago
Sandoz price target raised to CHF 72 from CHF 66 at Berenberg
PremiumThe FlySandoz price target raised to CHF 72 from CHF 66 at Berenberg
29d ago
Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity
Premium
Company Announcements
Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity
1M ago
Sandoz Unveils Bio100 Plan to Drive Golden Decade of Biosimilars
Premium
Company Announcements
Sandoz Unveils Bio100 Plan to Drive Golden Decade of Biosimilars
1M ago
Sandoz initiated with a Buy at Erste Group
PremiumThe Fly
Sandoz initiated with a Buy at Erste Group
1M ago
Sandoz expands biosimilar pipeline with major Henlius collaboration
PremiumCompany Announcements
Sandoz expands biosimilar pipeline with major Henlius collaboration
2M ago
Sandoz price target raised to CHF 80 from CHF 75 at JPMorgan
PremiumThe Fly
Sandoz price target raised to CHF 80 from CHF 75 at JPMorgan
2M ago
Sandoz H1 2026 profits surge as biosimilars drive growth and strategy
PremiumCompany Announcements
Sandoz H1 2026 profits surge as biosimilars drive growth and strategy
2M ago
Sandoz takes steps to resolve U.S. generic medicine pricing litigation
PremiumThe FlySandoz takes steps to resolve U.S. generic medicine pricing litigation
2M ago
Sandoz seals major U.S. settlements in generic drug antitrust saga
Premium
Company Announcements
Sandoz seals major U.S. settlements in generic drug antitrust saga
2M ago
Sandoz confirms Brazil regulatory approval for new semaglutide treatment option
Premium
The Fly
Sandoz confirms Brazil regulatory approval for new semaglutide treatment option
2M ago
Sandoz wins Brazilian approval for new semaglutide diabetes treatment
PremiumCompany Announcements
Sandoz wins Brazilian approval for new semaglutide diabetes treatment
2M ago
Sandoz Reshapes Leadership to Seize Generics Growth Wave
PremiumCompany Announcements
Sandoz Reshapes Leadership to Seize Generics Growth Wave
3M ago
PremiumCompany Announcements
Sandoz to Join Swiss Market Index in Milestone for Post-Listing Growth
3M ago
Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide
PremiumThe Fly
Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide
3M ago
Sandoz maps biosimilars ‘golden decade’ with capital markets day and Slovenia hub visit
PremiumCompany AnnouncementsSandoz maps biosimilars ‘golden decade’ with capital markets day and Slovenia hub visit
4M ago
Sandoz opens flagship biosimilar R&D hub in Slovenia to anchor $1.1bn expansion
Premium
Company Announcements
Sandoz opens flagship biosimilar R&D hub in Slovenia to anchor $1.1bn expansion
4M ago
Sandoz marks 80 years of European antibiotics and urges EU action to protect supply
Premium
Company Announcements
Sandoz marks 80 years of European antibiotics and urges EU action to protect supply
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >